GEAS PERU
@GEAS_Peru
Followers
14
Following
10
Media
3
Statuses
11
Study group focused on systemic autoimmune disease from the @cientifica_sur #AlmenaraLupusCohort #AlmenaraRACohort #AlmenaraVasculitisCohort
Lima, Peru
Joined January 2026
Are you attending the #vasculitis2026? @VictorioPQ will be presenting two posters from the #AlmenaraVasculitisCohort this Sunday! Thanks @anzvasc for organizing this meeting!
0
1
4
Mantente atento para conocer toda la nueva información que te traeremos de nuestro programa Pro&Pub. #GLADEL #ProAndPub #LES #Lupus #SLE #Research #LatinAmerica
0
1
4
Excited to share our latest publication with PANLAR 🌎👋🏽 Depression Rates Among Rheumatologists from Latin America Read full article here: https://t.co/62PjD6C67l
1
5
6
La presencia de @soc_peru con el Dr. @mugartegil, grandes tópicos de Lupus y las expectativas de mayor control y remisión de la enfermedad.. podemos visualizar un patrón de actividad baja crónica.. #Reumatología 🇲🇽 @ColMexReuma
0
1
3
Gracias por la invitación! Fue un honor participar del congreso de @ColMexReuma!
La presencia de @soc_peru con el Dr. @mugartegil, grandes tópicos de Lupus y las expectativas de mayor control y remisión de la enfermedad.. podemos visualizar un patrón de actividad baja crónica.. #Reumatología 🇲🇽 @ColMexReuma
0
1
4
Today @mugartegil talked about prolonged #remission in #SLE at the @ColMexReuma meeting. Prolonged remission is still rare, and patients still have a risk of flare higher than 30%. #AlmenaraLupusCohort @gladel_latam #SLICC
0
1
5
Quiero agradecer al @ColMexReuma por invitarme a hablar de #Remision prolongada en #LES representando a la @sociedadpereuma… un recuerdo especial al Dr. Javier Jara que fue siempre un apoyo para ambas instituciones @gladel_latam @GEAS_Peru
0
1
8
🆕paper ⬆️ prednisone daily dose is associated with worse #PROs in #SLE patients who have already reached #LLDAS. We need to reduce prednisone, even in patients with #LLDAS. It was led by @Asinghrheum #AlmenaraLupusCohort and it was published at @jrheum
jrheum.org
Objective To evaluate the association between the daily GC dose and various patient-reported outcomes (PROs) in patients who have achieved lupus low disease activity state (LLDAS). Methods Patients...
0
6
10
🆕paper: ⬆️prednisone dose is associated with ⬇️ HRQoL ⬆️ fatigue & ⬆️ patient-reported disease activity. Project lead by @Asinghrheum #AlmenaraLupusCohort published in @jrheum
https://t.co/jeUOu2P3u0
1
4
4